Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
- PMID: 15037694
- DOI: 10.1212/01.wnl.0000115115.98960.37
Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
Abstract
Background: Pathologic changes in the Alzheimer disease (AD) brain occur in a hierarchical neuroanatomical pattern affecting cortical, subcortical, and limbic regions.
Objective: To define the time course of pathologic and biochemical changes-amyloid deposition, amyloid beta-peptide (Abeta) accumulation, neurofibrillary tangle (NFT) formation, synaptic loss, and gliosis-within the temporal association cortex of AD cases of varying disease duration, relative to control brains.
Methods: Stereologic assessments of amyloid burden and tangle density as well as ELISA-based measurements of Abeta, synaptophysin, and glial fibrillary acidic protein (GFAP) were performed in the superior temporal sulcus from a cohort of 83 AD and 26 nondemented control brains.
Results: Relative to control cases, AD brains were characterized by accumulation of NFT and amyloid plaques, increase of tris- and formic acid-extractable Abeta species, reduced levels of synaptophysin, and elevated levels of GFAP. In AD cases, the duration of dementia correlated with the degree of tangle formation, gliosis, and synaptic loss but not with any Abeta measures. Accumulation of Abeta, measured both neuropathologically and biochemically, was markedly increased in AD brains independent of disease duration, even in cases of short duration.
Conclusions: These data support distinct processes in the initiation and progression of AD pathology within the temporal cortex: Deposition of Abeta reaches a "ceiling" early in the disease process, whereas NFT formation, synaptic loss, and gliosis continue throughout the course of the illness.
Similar articles
-
Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.Am J Pathol. 1999 Sep;155(3):853-62. doi: 10.1016/s0002-9440(10)65184-x. Am J Pathol. 1999. PMID: 10487842 Free PMC article.
-
Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects.J Neuropathol Exp Neurol. 2001 Jul;60(7):731-9. doi: 10.1093/jnen/60.7.731. J Neuropathol Exp Neurol. 2001. PMID: 11444802
-
Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.Acta Neuropathol. 2012 Nov;124(5):681-92. doi: 10.1007/s00401-012-1044-y. Epub 2012 Sep 12. Acta Neuropathol. 2012. PMID: 22968369 Free PMC article.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
-
Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.Metabolism. 2015 Mar;64(3 Suppl 1):S51-7. doi: 10.1016/j.metabol.2014.10.033. Epub 2014 Oct 30. Metabolism. 2015. PMID: 25468143 Review.
Cited by
-
Neurosteroid [3α,5α]-3-Hydroxy-pregnan-20-one Enhances the CX3CL1-CX3CR1 Pathway in the Brain of Alcohol-Preferring Rats with Sex-Specificity.Life (Basel). 2024 Jul 9;14(7):860. doi: 10.3390/life14070860. Life (Basel). 2024. PMID: 39063614 Free PMC article.
-
Conformation-dependent oligomers in cerebrospinal fluid of presymptomatic familial Alzheimer's disease mutation carriers.Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):652-7. doi: 10.1159/000345771. Epub 2012 Dec 15. Dement Geriatr Cogn Dis Extra. 2012. PMID: 23341831 Free PMC article.
-
T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment.Neuroimage. 2021 Sep;238:118214. doi: 10.1016/j.neuroimage.2021.118214. Epub 2021 Jun 9. Neuroimage. 2021. PMID: 34116150 Free PMC article.
-
Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound.Biomolecules. 2022 Oct 2;12(10):1409. doi: 10.3390/biom12101409. Biomolecules. 2022. PMID: 36291618 Free PMC article. Review.
-
Presenilin-1 adopts pathogenic conformation in normal aging and in sporadic Alzheimer's disease.Acta Neuropathol. 2013 Feb;125(2):187-99. doi: 10.1007/s00401-012-1065-6. Epub 2012 Nov 9. Acta Neuropathol. 2013. PMID: 23138650 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous